Stock Screener App

Gratuito -

4.23

2.31% -0.10

Synaptogenix Inc (SNPX)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione Frazionamento azionario

Synaptogenix Inc Borsa (SNPX) Ultime notizie

Synaptogenix CEO Dr. Tuchman's Tenure Extended Through 2024 - TipRanks.com - TipRanks

Alzamend Neuro (NASDAQ:ALZN) Stock Quotes, Forecast and News Summary - Benzinga

Synaptogenix (NASDAQ:SNPX) Stock Price Up 1% - Defense World

SNPX Stock Earnings: Synaptogenix Reported Results for Q1 2024 - MSN

SNPX Stock Earnings: Synaptogenix Reported Results for Q1 2024 - MSN

SNPX Stock Earnings: Synaptogenix Reported Results for Q1 2024 - MSN

SNPX Stock Earnings: Synaptogenix Reported Results for Q1 2024 - MSN

Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for ... - Investing.com India

Investing.com India

Synaptogenix regains Nasdaq listing compliance By Investing.com - Investing.com

Synaptogenix increases psilocybin stake with PsygaBio - Green Market Report

Green Market Report

What's Going On With Synaptogenix (SNPX) Stock? - Synaptogenix (NASDAQ:SNPX) - Benzinga

Synaptogenix announces reverse stock split to regain Nasdaq compliance By Investing.com - Investing.com

Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Markets Insider

Markets Insider

CERo Therapeutics Hldgs (NASDAQ:CERO) Stock Quotes, Forecast and News Summary - Benzinga

Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Why Sintx Technologies Shares Are Trading Higher By Over 39%; Here Are 20 Stocks Moving Premarket

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday - InvestorPlace

Synaptogenix President Daniel L. Alkon, M.D. Honored for Scientific Presentation at USC-Sponsored Forum on Age ... - PR Newswire

Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of ... - PR Newswire

Synaptogenix trial - 'extremely important' outcome for Alzheimer's - OutSourcing-Pharma.com

OutSourcing-Pharma.com

Advanced Alzheimer's: Bryostatin-1 may be safe, effective - Medical News Today

Medical News Today

Bryostatin found to slow cognitive decline in advanced Alzheimer's... - Alzheimer's News Today

Alzheimer's News Today

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.31% - Investing.com India

Investing.com India

In lab model of ALS, bryostatin-1 boosts cell survival | ALS News... - ALS News Today

Best Penny Stocks To Buy Now? 3 Under $1 To Watch - Penny Stocks

Phase 1 trial of bryostatin-1 in MS expected by year's end |... - Multiple Sclerosis News Today

Multiple Sclerosis News Today

Synaptogenix reports data from Phase II Alzheimer's trial - Clinical Trials Arena

Clinical Trials Arena

Why Is Synaptogenix (SNPX) Stock Plummeting 70% Today? - InvestorPlace

Synaptogenix (SNPX): Bryostatin For Alzheimer's, As Binary As Can Be - Seeking Alpha

Synaptogenix Closes $15 Million Private Placement - citybiz

Theriva Biologics Stock (AMEX:TOVX), Quotes and News Summary - Benzinga

Roche's drug failure extends long list of Alzheimer's trial setbacks - Reuters

Investor pleads guilty to insider trading in Alzheimer's biotech - Fierce Biotech

Clinical Catch-Up: Prometheus, Algernon, Seelos, Inozyme and Takeda - BioSpace

Synaptogenix concludes subject enrolment in Phase IIb Alzheimer's trial - Clinical Trials Arena

Clinical Trials Arena

Synaptogenix Inc (NASDAQ: SNPX) Announces a Peer-reviewed Paper on Bryostatin - BP Journal

Synaptogenix Inc. (NASDAQ: SNPX) Announce Publication of Peer-Reviewed Data of Bryostatin Study in AD in Journal ... - BP Journal

Synaptogenix (SNPX) Stock Price, News & Analysis - MarketBeat

Alzamend Neuro (NASDAQ:ALZN) Stock Quotes, Forecast and News Summary - Benzinga

Neurotrope completes formation of new company Synaptogenix - NeuroNews International

NeuroNews International

$146.84

2.64%

$85.34

0.38%

$25.71

0.25%

$84.20

2.90%

$447.85

0.91%

$246.82

2.73%

Apri su Yahoo | Apri su Google | Aperto in Finviz